RuxolitinibVarious toxicities following off-label use : 19 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1872卷 / 1期

关键词：

D O I：

10.1007/s40278-021-02373-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：447 / 447

相关论文

共 50 条

[1] RuxolitinibVarious toxicities following off-label use: 6 case reports
[J]. Reactions Weekly, 2020, 1810 (1) : 185 - 185
[2] RuxolitinibVarious toxicities following off-label use: 5 case reports
[J]. Reactions Weekly, 2023, 1965 (1) : 433 - 433
[3] RuxolitinibVarious infections following off-label use: 6 case reports
[J]. Reactions Weekly, 2019, 1739 (1) : 227 - 227
[4] Abatacept/immunosuppressants/ruxolitinibVarious toxicities following off-label use and lack of efficacy: 20 case reports
[J]. Reactions Weekly, 2022, 1904 (1) : 15 - 15
[5] IvermectinVarious toxicities following off-label use: 7 case reports
[J]. Reactions Weekly, 2022, 1919 (1) : 335 - 335
[6] DasatinibVarious toxicities following off-label use: 3 case reports
[J]. Reactions Weekly, 2021, 1881 (1) : 92 - 92
[7] PazopanibVarious toxicities following off-label use: 3 case reports
[J]. Reactions Weekly, 2023, 1939 (1) : 375 - 375
[8] ImatinibVarious toxicities following off-label use: 5 case reports
[J]. Reactions Weekly, 2021, 1876 (1) : 164 - 164
[9] RituximabVarious toxicities following an off-label use: 3 case reports
[J]. Reactions Weekly, 2018, 1683 (1) : 600 - 600
[10] AmisulprideVarious toxicities following off-label use: 6 case reports
[J]. Reactions Weekly, 2019, 1766 (1) : 22 - 23

← 1 2 3 4 5 →